5573; (e) N. Boyer, P. Gloanec, G. De Nanteuil, P. Jubault and J.-C.
Quirion, Tetrahedron, 2007, 63, 12352.
Acknowledgements
10 The Zn-mediated, CeCl3-catalyzed Barbier reactions of chiral imines
with allyl bromide provided high diastereoselectivities, see: T. Basile,
A. Bocoum, D. Savoia and A. Umani-Ronchi, J. Org. Chem., 1994, 59,
7766.
We thank the Ministere de la Recherche et de l¢Enseignement
Supe´rieur and the Agence Nationale de Recherche (ANR) for
their financial support.
11 T. Vilaivan, C. Winotapan, V. Banphavichit, T. Shinada and Y. Ohfune,
J. Org. Chem., 2005, 70, 3464.
12 The use of hydrogenolysis deprotection conditions was not possible
with 2.
13 Compound 5 was treated with diazomethane to give analytically pure
ester compared to reported 1H, 13C NMR and [a]D values. C. Flamant-
Robin, Q. Wang, A. Chiaroni and N. A. Sasaki, Tetrahedron, 2002, 58,
10475.
14 (a) C. J. Rousset, D. R. Swanson, F. Lamaty and E. Negishi, Tetrahedron
Lett., 1989, 30, 5105; (b) H. Ito, T. Taguchi and Y. Hanzawa,
Tetrahedron Lett., 1992, 33, 1295; (c) H. Ito, T. Nakamura, T. Taguchi
and Y. Hanzawa, Tetrahedron, 1995, 51, 4507.
15 Allylzirconocenes typically add to carbonyl compounds in a g-
regioselective manner with predominant anti-stereoselectivity; see: K.
Mishima, H. Yasuda, T. Asami and A. Nakamura, Chem. Lett., 1983,
219.
16 (a) Y. Yamamoto, S. Nishi, K. Maruyama, T. Komatsu and W. Ito,
J. Am. Chem. Soc., 1986, 108, 7778; (b) K. Fujita, H. Yorimitsu, H.
Shinokubo and K. Oshima, J. Org. Chem., 2004, 69, 3302.
17 (a) The reactions of allylic metals with imines are often capricious, for
reviews see: W. Roush, Comprehensive Organic Synthesis, B. M. Trost,
I. Fleming, C. W. Heathock, ed.; Pergamon, Oxford, 1991; Vol. 2, p. 1.;
(b) Y. Yamamoto and N. Asao, Chem. Rev., 1993, 93, 2207.
18 No product was observed when adding benzyloxyacetaldehyde-derived
imine 1 to A.
19 The predominant syn selectivity was observed in the reaction of imines
with allylic zirconocenes also in the absence of additives, see ref. 16.
20 A. Sato, I. Hisanaka, M. Okada, Y. Nakamura and T. Taguchi,
Tetrahedron Lett., 2005, 46, 8381.
21 (a) P. Wipf and C. Kendall, Chem.–Eur. J., 2002, 8, 1779 and references
therein; P. Wipf, C. Kendall, Topics in Organometallic Chemistry, ed.
T. Takahashi, Springer, Berlin, 2004, Vol. 8, p. 1; (b) P. Wipf and J. G.
Pierce, Org. Lett., 2005, 7, 3537.
Notes and references
1 (a) C. Armishaw, A. A. Jensen, T. Balle, R. J. Clark, K. Harpsoe, C.
Skonberg, T. Liljefors and K. Stromgaard, J. Biol. Chem., 2009, 284,
9498; (b) S. Hanessian and L. Auzzas, Acc. Chem. Res., 2008, 41, 1241;
(c) S. Pujals and E. Giralt, Adv. Drug Delivery Rev., 2008, 60, 473; (d) G.
Burton, T. W. Ku, T. J. Carr, T. Kiesow, R. T. Sarisky, J. Lin-Goerke,
A. Baker, D. L. Earnshaw, G. A. Hofmann, R. M. Keenan and D.
Dhanak, Bioorg. Med. Chem. Lett., 2005, 15, 1553.
2 For a review on proline chimeras, see: P. Karoyan, S. Sagan, O. Lequin,
J. Quancard, S. Lavielle and G. Chassaing, Targets Heterocycl. Syst,
2004, 8, 216.
3 (a) V. J. Hruby and P. M. Balse, Curr. Med. Chem., 2000, 7, 945; (b) K.
Sugase, M. Horikawa, M. Sugiyama and M. Ishiguro, J. Med. Chem.,
2004, 47, 489; (c) S. Sagan, J. Quancard, O. Lequin, P. Karoyan, G.
Chassaing and S. Lavielle, Chem. Biol., 2005, 12, 5.
4 (a) D. K. Chalmers and G. R. Marshall, J. Am. Chem. Soc., 1995, 117,
5927; (b) J. Quancard, P. Karoyan, O. Lequin, E. Wenger, A. Aubry, G.
Chassaing and S. Lavielle, Tetrahedron Lett., 2004, 45, 623.
5 Y. Jacquot, I. Broutin, E. Miclet, M. Nicaise, N. Gouasdoue, C. Joss,
P. Karoyan, M. Desmadril, A. Ducruix and S. Lavielle, Bioorg. Med.
Chem., 2007, 15, 1439.
6 For relevant syntheses, see: (a) D. Damour, F. Herman, R.
Labaudinie`re, G. Pantel, M. Vuilhorgne and S. Mignani, Tetrahedron,
1999, 55, 10135; (b) N. Pellegrini, M. Schmitt, S. Guery, S. and J. J.
Bourguignon, Tetrahedron Lett., 2002, 43, 3243; (c) J. Quancard, A.
Labonne, Y. Jacquot, S. Lavielle, G. Chassaing and P. Karoyan, J. Org.
Chem., 2004, 69, 7940; (d) C. Mothes, S. Lavielle and P. Karoyan, J. Org.
Chem., 2008, 73, 6706 and references therein.
7 (a) J.-L. Vasse, A. Joosten, C. Denhez and J. Szymoniak, Org. Lett.,
2005, 7, 4887; (b) M. Ahari, A. Joosten, J.-L. Vasse and J. Szymoniak,
Synthesis, 2008, (1), 61; (c) M. Ahari, A. Perez, C. Menant, J.-L. Vasse
and J. Szymoniak, Org. Lett., 2008, 10, 2473.
22 Compound 1¢¢rather than 1 was chosen owing to the anticipated
incompatibility of Ru-based oxidation conditions with the presence
of the Boc-protected indolyl group.
23 Improvement in the anti diastereoselectivity was observed for the
reactions of allylic zirconocenes with aldehydes, see ref. 14b.
24 S. K. Latypov, J. M. Seco, E. Quinoa` and R. Riguera, J. Org. Chem.,
1995, 60, 1538.
25 The use of H2 in the presence of Pd/C catalyst led to exclusive
N-deprotection; the inhibition of O-debenzylation by nonaromatic
amines has been reported; see: B. P. Czech and R. A. Bartsch, J. Org.
Chem., 1984, 49, 4076.
8 P.-O. Delaye, T. K. Pradhan, E. Lambert, J.-L. Vasse and J.
Szymoniak, J., Eur. J. Org. Chem., 2010, 3395.
9 (a) For recent examples of diastereoselective addition of
organometallics to chiral phenylglycinol-derived imines, see: A. Enz,
D. Feuerbach, M. U. Frederiksen, C. Gentsch, K. Hurth, W. Mu¨ller,
J. Nozulak and B. L. Roy, Bioorg. Med. Chem. Lett., 2009, 19, 1287;
(b) J. Alladoum, S. Roland, E. Vrancken, P. Mangeney and C. Kadouri-
Puchot, J. Org. Chem., 2008, 73, 9771; (c) V. G. Albano, A. Gualandi,
M. Monari and D. Savoia, J. Org. Chem., 2008, 73, 8376; (d) G. Alvaro,
R. Di Fabio, A. Gualandi and D. Savoia, Eur. J. Org. Chem., 2007,
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 3635–3637 | 3637
©